Business Description
Eocene Ltd., headquartered in Ramat Gan, Israel, is a medical research company working to create new treatments for liver disease and related conditions. Its leading drug candidate, Aramchol, is currently in late-stage clinical trials targeting a serious liver condition linked to obesity and diabetes, with additional studies exploring its use in HIV patients. The company also has several other treatments in earlier stages of development, including a short protein molecule and a gut microbiome therapy, both aimed at liver disease and scarring. Founded in 2000 and formerly known as Galmed Pharmaceuticals, Eocene has built partnerships with companies in South Korea and elsewhere to advance its research and bring its treatments to market.
